10/4/23 15:31 | 10/2/23 | MGNX | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 670 | 4.46 | 0 | 150 | 2 | 9,930 | D | | | | | | | | | | | | | | |
9/11/23 15:39 | 9/7/23 | MGNX | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 1,053 | 5.26 | 0 | 200 | 2 | 9,780 | D | | | | | | | | | | | | | | |
9/1/23 16:06 | 8/30/23 | MGNX | Health | Drug | Pharmaceutical Preparations | Hurwitz Edward | MD | D | | P | 74 | 4.91 | 0 | 15 | 83 | 33 | D | | | | | | | | | | | | | | |
2/16/23 12:37 | 2/14/23 | MGNX | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 2,533 | 5.07 | 0 | 500 | 6 | 9,580 | D | | | | | | | | | | | | | | |
1/23/23 16:21 | 1/19/23 | MGNX | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 795 | 5.30 | 0 | 150 | 2 | 9,080 | D | | | | | | | | | | | | | | |
12/28/22 11:03 | 12/23/22 | MGNX | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P.m | 2,299 | 5.75 | 0 | 400 | 5 | 8,930 | D | | | | | | | | | | | | | | |
11/25/22 11:37 | 11/22/22 | MGNX | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 1,788 | 5.96 | 0 | 300 | 4 | 8,530 | D | | | | | | | | | | | | | | |
10/25/22 16:19 | 10/21/22 | MGNX | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P.m | 2,248 | 4.50 | 0 | 500 | 6 | 8,230 | D | | | | | | | | | | | | | | |
10/21/22 15:03 | 10/19/22 | MGNX | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P.m | 1,767 | 3.89 | 0 | 454 | 6 | 7,730 | D | | | | | | | | | | | | | | |
6/17/22 16:18 | 6/15/22 | MGNX | Health | Drug | Pharmaceutical Preparations | Karrels James | MD | O | SVP,CFO, | P | 99 | 2.47 | 0 | 40 | 26 | 192 | D | | | | | | | | | | | | | | |
11/23/21 12:29 | 11/19/21 | MGNX | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 3,700 | 18.50 | 0 | 200 | 3 | 7,276 | D | | | | | | | | | | | | | | |
9/30/21 15:09 | 9/28/21 | MGNX | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P.m | 4,111 | 20.56 | 0 | 200 | 3 | 7,076 | D | | | | | | | | | | | | | | |
9/20/21 12:21 | 9/16/21 | MGNX | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P.m | 12,363 | 20.61 | 0 | 600 | 10 | 6,876 | D | | | | | | | | | | | | | | |
6/23/21 13:33 | 6/21/21 | MGNX | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P | 1,630 | 21.74 | 0 | 75 | 1 | 6,276 | D | | | | | | | | | | | | | | |
6/17/21 14:54 | 6/15/21 | MGNX | Health | Drug | Pharmaceutical Preparations | Biotech Target N V | P8 | T | | P.m | 3,644 | 20.82 | 0 | 175 | 3 | 6,201 | D | | | | | | | | | | | | | | |
3/4/16 08:12 | 3/3/16 | MGNX | Health | Drug | Pharmaceutical Preparations | Costa Paulo F | MD | D | | P | 172 | 17.20 | 5 | 10 | 20 | 59 | D | -50 | -50 | -33 | -50 | -19 | 12 | 9 | 7 | 8 | -3 | 16 | 60 | 74 | 19 |
10/18/13 14:36 | 10/16/13 | MGNX | Health | Drug | Pharmaceutical Preparations | Galbraith Kenneth | MD | D | | P.d | 750 | 16.00 | 28 | 47 | 4 | 1,317 | I | | | | | | | | -1 | 1 | 11 | 8 | 60 | -24 | -27 |